News
MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.
MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and ...
MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...
Cryptopolitan on MSN14d
Big Pharma joins crypto with a private placement for $100 Million Litecoin Treasury Strategy
MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.
MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.
MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...
A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...
GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.
invezz on MSN14d
GSR leads $100M private placement into Nasdaq-listed MEI Pharma to launch first institutional Litecoin treasury strategy alongside Charlie Lee
Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...
Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied above $3,600, Litecoin surpassed the $100 psychological zone. LTC gained more ...
How companies like MicroStrategy and SharpLink are using crypto treasury strategies to reshape corporate finance with bitcoin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback